Regeneron Pharmaceuticals, Inc. (REGN) SEC Filings — 2025
13 SEC filings for Regeneron Pharmaceuticals, Inc. (REGN) in 2025.
Filings
- Regeneron Pharmaceuticals, Inc. 13F-HR Filing — 13F-HR · Nov 7, 2025
- Regeneron's Collaboration Gains Offset EYLEA Sales Dip, Net Income Rises — 10-Q · Oct 28, 2025
- Regeneron Pharmaceuticals Files 8-K on Financials — 8-K · Oct 6, 2025
- Regeneron Pharmaceuticals, Inc. 13F-HR Filing — 13F-HR · Aug 1, 2025
- Regeneron Posts Modest Q2 Revenue Growth Amidst Steady Product Sales — 10-Q · Aug 1, 2025
- Regeneron Pharmaceuticals Reports on Shareholder Vote Matters — 8-K · Jun 18, 2025
- Regeneron Pharmaceuticals, Inc. 13F-HR Filing — 13F-HR · May 2, 2025
- Regeneron Files Q1 2025 10-Q — 10-Q · Apr 29, 2025
- Regeneron Files 2025 Proxy Statement on Executive Compensation — DEF 14A · Apr 29, 2025
- Regeneron Pharmaceuticals, Inc. 13F-HR Filing — 13F-HR · Feb 7, 2025
- Regeneron Pharmaceuticals Files 2024 10-K — 10-K · Feb 5, 2025
- Regeneron Pharmaceuticals Files 8-K — 8-K · Feb 4, 2025
- Regeneron Pharmaceuticals, Inc. 8-K Filing — 8-K · Jan 13, 2025